On the 13th of February, Laerdal Global Health sent in an application for funding the research and development of four new innovative products that will help decrease newborn mortality and morbidity worldwide.
Monday 10th of June, the GLOBVAC board decides on their board meeting that this project is one of two who is approved for funding. The project is called Safer Births and with this funding the basis for extensive research and development work in mainly Norway and Tanzania is made for the next four years.
The grant is made conditional. The condition is based on satisfactory documentation of the applicants’ implementation capacity, both for the research project and the innovation. We now look forward to go into cooperation with the Research Council of Norway.